Veeva Systems (NYSE: VEEV) has recently received a number of price target changes and ratings updates:
- 10/29/2026 – Veeva Systems was given a new $345.00 price target by Mizuho.
- 10/28/2026 – Veeva Systems had its price target raised by Barclays from $360.00 to $375.00. They now have an “overweight” rating on the stock.
- 10/26/2026 – Veeva Systems had its price target raised by Robert W. Baird from $300.00 to $350.00. They now have an “outperform” rating on the stock.
- 10/19/2026 – Veeva Systems had its price target raised by Barclays from $315.00 to $360.00. They now have an “overweight” rating on the stock.
- 10/15/2026 – Veeva Systems had its “outperform” rating reaffirmed by Oppenheimer. They now have a $325.00 price target on the stock.
- 10/10/2026 – Veeva Systems was upgraded by Wall Street Zen from “hold” to “buy”.
- 10/8/2026 – Veeva Systems was upgraded by Weiss Ratings from “hold (c)” to “hold (c+)”.
- 9/26/2026 – Veeva Systems was downgraded by Wall Street Zen from “buy” to “hold”.
- 9/12/2026 – Veeva Systems was upgraded by Wall Street Zen from “hold” to “buy”.
- 9/8/2026 – Veeva Systems had its “overweight” rating reaffirmed by Wells Fargo & Company. They now have a $330.00 price target on the stock.
Veeva Systems Trading Up 2.5%
Shares of VEEV stock opened at $310.79 on Thursday. Veeva Systems Inc. has a 12 month low of $148.05 and a 12 month high of $325.99. The company’s fifty day moving average price is $287.53 and its 200-day moving average price is $211.07. The stock has a market cap of $50.32 billion, a PE ratio of 51.12, a price-to-earnings-growth ratio of 1.29 and a beta of 0.89.
Veeva Systems (NYSE:VEEV – Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The technology company reported $2.35 earnings per share for the quarter, topping analysts’ consensus estimates of $2.23 by $0.12. The business had revenue of $927.96 million for the quarter, compared to analysts’ expectations of $905.38 million. Veeva Systems had a net margin of 29.34% and a return on equity of 14.25%. The business’s revenue was up 17.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.99 earnings per share. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. On average, sell-side analysts forecast that Veeva Systems Inc. will post 6.70 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other news, insider Thomas D. Schwenger sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, August 27th. The shares were sold at an average price of $281.33, for a total transaction of $2,813,300.00. Following the completion of the transaction, the insider directly owned 19,449 shares of the company’s stock, valued at $5,471,587.17. The trade was a 33.96% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Priscilla Hung sold 750 shares of the business’s stock in a transaction on Wednesday, September 9th. The shares were sold at an average price of $261.04, for a total transaction of $195,780.00. Following the sale, the director owned 3,242 shares of the company’s stock, valued at approximately $846,291.68. This represents a 18.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 56,789 shares of company stock worth $14,913,889 in the last 90 days. 10.60% of the stock is currently owned by company insiders.
Veeva Systems Inc is a cloud software company that develops technology for the life sciences industry. Its customers include pharmaceutical, biotechnology, medical device and other healthcare companies that use Veeva’s applications to manage commercial, clinical, regulatory, quality and operational processes.
The company’s Veeva Vault platform provides cloud applications for areas such as clinical data management, electronic trial management, regulatory information, quality management, safety and content management.
Read More
- Five stocks we like better than Veeva Systems
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Veeva Systems Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems Inc and related companies with MarketBeat.com's FREE daily email newsletter.
